Authors:
FRY DW
BRIDGES AJ
DENNY WA
DOHERTY A
GREIS KD
HICKS JL
HOOK KE
KELLER PR
LEOPOLD WR
LOO JA
MCNAMARA DJ
NELSON JM
SHERWOOD V
SMAILL JB
TRUMPPKALLMEYER S
DOBRUSIN EM
Citation: Dw. Fry et al., SPECIFIC, IRREVERSIBLE INACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ERBB2, BY A NEW CLASS OF TYROSINE KINASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 12022-12027
Citation: Ja. Bikker et al., G-PROTEIN COUPLED RECEPTORS - MODELS, MUTAGENESIS, AND DRUG DESIGN, Journal of medicinal chemistry, 41(16), 1998, pp. 2911-2927
Authors:
TRUMPPKALLMEYER S
RUBIN JR
HUMBLET C
HAMBY JM
SHOWALTER HDH
Citation: S. Trumppkallmeyer et al., DEVELOPMENT OF A BINDING MODEL TO PROTEIN-TYROSINE KINASES FOR SUBSTITUTED PYRIDO[2,3-D]PYRIMIDINE INHIBITORS, Journal of medicinal chemistry, 41(11), 1998, pp. 1752-1763
Authors:
BOURDON H
TRUMPPKALLMEYER S
SCHREUDER H
HOFLACK J
HIBERT M
WERMUTH CG
Citation: H. Bourdon et al., MODELING OF THE BINDING-SITE OF THE HUMAN M(1) MUSCARINIC RECEPTOR - EXPERIMENTAL VALIDATION AND REFINEMENT, Journal of computer-aided molecular design, 11(4), 1997, pp. 317-332
Authors:
PALMER BD
TRUMPPKALLMEYER S
FRY DW
NELSON JM
SHOWALTER HDH
DENNY WA
Citation: Bd. Palmer et al., TYROSINE KINASE INHIBITORS .11. SOLUBLE ANALOGS OF PYRROLOQUINAZOLINES AND PYRAZOLOQUINAZOLINES AS EPIDERMAL GROWTH-FACTOR RECEPTOR INHIBITORS - SYNTHESIS, BIOLOGICAL EVALUATION, AND MODELING OF THE MODE OF BINDING, Journal of medicinal chemistry, 40(10), 1997, pp. 1519-1529
Authors:
CHINI B
MOUILLAC B
BALESTRE MN
TRUMPPKALLMEYER S
HOFLACK J
HIBERT M
ANDRIOLO M
PUPIER S
JARD S
BARBERIS C
Citation: B. Chini et al., 2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN, FEBS letters, 397(2-3), 1996, pp. 201-206
Authors:
CHINI B
MOUILLAC B
ALA Y
BALESTRE MN
TRUMPPKALLMEYER S
HOFLACK J
ELANDS J
HIBERT M
MANNING M
JARD S
BARBERIS C
Citation: B. Chini et al., TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR, EMBO journal, 14(10), 1995, pp. 2176-2182
Authors:
MOUILLAC B
CHINI B
BALESTRE MN
ELANDS J
TRUMPPKALLMEYER S
HOFLACK J
HIBERT M
JARD S
BARBERIS C
Citation: B. Mouillac et al., THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS, The Journal of biological chemistry, 270(43), 1995, pp. 25771-25777
Citation: J. Hoflack et al., REEVALUATION OF BACTERIORHODOPSIN AS A MODEL FOR G-PROTEIN-COUPLED RECEPTORS, Trends in pharmacological sciences, 15(1), 1994, pp. 7-9
Authors:
HERBETTE L
GALLION S
RHODES D
HIBERT M
HOFLACK J
TRUMPPKALLMEYER S
JENKINS D
TRUMBORE M
Citation: L. Herbette et al., MOLECULAR DYNAMIC SIMULATIONS OF DRUGS, PEPTIDES AND PROTEINS IN LIPID BILAYERS, Biophysical journal, 66(2), 1994, pp. 10000386-10000386
Authors:
HUGGINS JP
TRUMPPKALLMEYER S
HIBERT MF
HOFLACK JM
FANGER BO
JONES CR
Citation: Jp. Huggins et al., MODELING AND MODIFICATION OF THE BINDING-SITE OF ENDOTHELIN AND OTHERRECEPTORS, European journal of pharmacology. Molecular pharmacology section, 245(3), 1993, pp. 203-214